InterCure Ltd. [NASDAQ: INCR] disclosed that its CEO Alex Rabinovitch has acquired a total of 423,501 shares of the Company’s common stock throughout the month of September 2021 in the Open Market. InterCure has earned a reputation as the leading, profitable, and fastest-growing cannabis company outside of North America.
INCR revealed that Mr. Rabinovitch acquired the shares by purchase 423,501 shares in the open market at an average price of USD$7.03 per share (CAD $8.95 or NIS 22.69). The shares were acquired partially on the NASDAQ and in part on the Tel Aviv Stock Exchange, for a total investment in the Company of USD$2,975,730 (CAD $3,790,238 per share or NIS 9,608,631).
Shares of INCR surged 1.34% as the firm gained +0.09 during the trading session of Monday. In the past 52-weeks of a trading session, the share of the firm fluctuated between the 52-weeks low and high range of $2.01 and $12.72, respectively. The firm has recorded a total market capitalization of $365.13 million at the time of writing.